CoreCap Advisors’s Astera Labs ALAB Stock Holding History

CoreCap Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$267K	Buy	749 +130	+21%	+$41.8K	0.01%	751
2026 Q2	$299K	Buy	619 +596	+2,591%	+$158K	0.01%	710
2026 Q1	$2.52K	Sell	23 -1,311	-98%	-$187K	﹤0.01%	2353
2025 Q4	$222K	Buy	1,334 +605	+83%	+$101K	0.01%	759
2025 Q3	$143K	Sell	729 -560	-43%	-$92.1K	0.01%	905
2025 Q2	$117K	Buy	1,289 +1,271	+7,061%	+$100K	﹤0.01%	933
2025 Q1	$1.07K	Sell	18 -95	-84%	-$8.79K	﹤0.01%	2513
2024 Q4	$15K	Buy	+113	New	+$10.6K	﹤0.01%	1628

Other funds holding ALAB

Salem Investment Counselors Winston Salem, North Carolina $4.01B AUM 48.23% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Oak Grove Capital North Hampton, New Hampshire $2.21B AUM 127.51% 1-Year Est. Return

Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return

CoreCap Advisors's ALAB Position: Q3 2026 in Review

CoreCap Advisors increased its Astera Labs (ALAB) stake by 21% in Q3 2026, buying an estimated $41.8K and bringing the position to 749 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #751.

CoreCap Advisors first reported a position in ALAB in Q4 2024 and has held it in 8 quarters since. The position peaked at $299K in Q2 2026. 175 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

CoreCap Advisors held 749 shares of Astera Labs worth $267K as of Q3 2026.
CoreCap Advisors bought 130 Astera Labs shares in Q3 2026, an estimated $41.8K.
Astera Labs made up 0.01% of CoreCap Advisors's portfolio in Q3 2026, its #751 holding.
CoreCap Advisors first reported a position in Astera Labs in Q4 2024 and has held it in 8 quarters since.
CoreCap Advisors's Astera Labs position peaked at $299K in Q2 2026.
175 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.